TACE combined with apatinib for the treatment of BCLC stage C of hepatocellular carcinoma: A restrospective controlled study.
Sign Up to like & getrecommendations! Published in 2018 at "Journal of Clinical Oncology"
DOI: 10.1200/jco.2018.36.4_suppl.445
Abstract: 445Background: To access the safety and effcacy of transarterial chemoembolization (TACE) combined with apatinib (TACE-apatinib) for the treatment of Barcelona Clinic Liver Cancer (BCLC) stage C of... read more here.
Keywords: tace; combined apatinib; tace combined; apatinib treatment ... See more keywords
IL-17 predicts the effect of TACE combined with apatinib in hepatocellular carcinoma.
Sign Up to like & getrecommendations! Published in 2020 at "Clinical hemorheology and microcirculation"
DOI: 10.3233/ch-200857
Abstract: OBJECTIVE IL-17 is considered to be a cancer-promoting gene in hepatocellular carcinoma (HCC). Here, we explored the effect of IL-17 in predicting the therapeutic effect of transcatheter arterial chemoembolization (TACE) combined with apartinib in patients… read more here.
Keywords: expression; combined apatinib; hcc; protein expression ... See more keywords
Microwave ablation combined with apatinib and camrelizumab in patients with advanced hepatocellular carcinoma: A single-arm, preliminary study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Immunology"
DOI: 10.3389/fimmu.2022.1023983
Abstract: Purpose The aim of this study was to assess the safety and efficacy of microwave ablation combined with apatinib [vascular endothelial growth factor receptor-2 (VEGFR-2) inhibitor] and camrelizumab [anti-programmed death-1 (PD-1) antibody] in patients with… read more here.
Keywords: microwave ablation; ablation; patients advanced; combined apatinib ... See more keywords
Transarterial chemoembolization combined with apatinib with or without PD-1 inhibitors in BCLC stage C hepatocellular carcinoma: A multicenter retrospective study
Sign Up to like & getrecommendations! Published in 2022 at "Frontiers in Oncology"
DOI: 10.3389/fonc.2022.961394
Abstract: Objective We evaluated the efficacy and safety of transarterial chemoembolization (TACE) combined with apatinib plus PD-1 inhibitors (TACE-AP) compared with TACE combined with apatinib (TACE-A) in patients with advanced hepatocellular carcinoma (HCC) and to explore… read more here.
Keywords: hepatocellular carcinoma; prognostic factors; factors affecting; tace ... See more keywords